1-5 of 5
receptors, histamine h1
Close
Sort by
Journal Articles

A Phase IIa, Open-Label, Multicenter Study of Single-Agent Tafasitamab (MOR208), an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma: Long-Term Follow-up, Final Analysis

Wojciech Jurczak, MD PhD, Pier Luigi Zinzani, MD PhD, Georg Hess, Gianluca Gaidano, MD PhD, Mariano Provencio, MD, Zsolt Nagy, MD PhD, Tadeusz Robak, MD, Kami J. Maddocks, MD, Christian Buske, MD PhD, Sumeet Ambarkhane, MD MBBS, Wolfram Brugger, Maren Dirnberger-Hertweck, PhD, Sascha Tillmanns, Johannes Weirather, PhD, Kristie Blum
Journal: Blood
Blood (2019) 134 (Supplement_1): 4078.
https://doi.org/10.1182/blood-2019-124297
Published: 2019
Journal Articles

A Murine Model of Asparaginase Allergy

Christian A. Fernandez, PhD, Colton Smith, PhD, Seth E. Karol, MD, Laura B. Ramsey, PhD, Chengcheng Liu, Ching-Hon Pui, MD, Sima Jeha, MD, William E. Evans, PharmD, Fred D. Finkelman, PhD, Mary V. Relling, PharmD
Journal: Blood
Blood (2014) 124 (21): 2295.
https://doi.org/10.1182/blood.V124.21.2295.2295
Published: 2014
Journal Articles

NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells

Bianca Esposito, Guido Gambara, Alexander M. Lewis, Fioretta Palombi, Alessio D'Alessio, Lewis X. Taylor, Armando A. Genazzani, Elio Ziparo, Antony Galione, Grant C. Churchill, Antonio Filippini
Journal: Blood
Blood (2011) 117 (18): 4968–4977.
https://doi.org/10.1182/blood-2010-02-266338
Published: 2011
Includes: Supplemental data
Journal Articles

CD34+ obtained from High Sokal Risk Chronic Myeloid Leukemia (CML) Patients (PTS) Expresses Gene Profiles (GEP) Significantly Different From CD34+ Obtained From Low Sokal Risk Patients.

Carolina Terragna, Sandra Durante, Annalisa Astolfi, Francesca Palandri, Fausto Castagnetti, Gianantonio Rosti, Nicoletta Testoni, Simona Luatti, Ilaria Iacobucci, PhD, Thea Kalebic, MD, Simona Soverini, Marilina Amabile, Angela Poerio, Michele Baccarani, Giovanni Martinelli
Journal: Blood
Blood (2009) 114 (22): 2174.
https://doi.org/10.1182/blood.V114.22.2174.2174
Published: 2009
Journal Articles

A High Throughput Screen Identified Cyproheptadine That Decreases D-Type Cyclins, Arrests Cells in the G1 Phase, and Induces Apoptosis in Multiple Myeloma and Leukemia Cells.

Xinliang Mao, PhD, A. Keith Stewart, MD, Rose Hurren, BSc, Marcela Gronda, MSc, Kyle Lee, BSc, Sue Chow, BSc, Shengben Liang, PhD, Suzanne Trudel, MD, David W. Hedley, MD, PhD, Aaron D. Schimmer, Md, PhD
Journal: Blood
Blood (2007) 110 (11): 1507.
https://doi.org/10.1182/blood.V110.11.1507.1507
Published: 2007